— Know what they know.
Not Investment Advice

NASC OTC

Nascent Pharma Holdings, Inc.
1W: -10.0% 1M: +12.5% 3M: -40.0% YTD: -40.0%
$0.01
+0.00 (+0.00%)
 
OTC · Healthcare · Drug Manufacturers - Specialty & Generic · Tech Score Sell · Power 50 · $682578 mcap · 74M float · 0.052% daily turnover · Short 65% of daily vol

Supply Chain Overview

19 relationships
19
As Filer
counterparties named
0
As Counterparty
mentioned by others
4
Rel. Types
2021-08-17
Earliest Filing
2024-10-28
Latest Filing
partner: 12 supplier: 4 investor: 2 customer: 1

Counterparties (Filed by NASC)

19 relationships

Companies named in NASC's SEC 8-K filings as business counterparties.

Counterparty Ticker Relationship Summary Filing Date SEC
Can B Corp. NASC partner Surviving entity in merger with Nascent Pharma Holdings, Inc. 2024-10-28 View
Nascent Pharma Holdings, Inc. — partner Merging entity in merger with Can B Corp. 2024-10-28 View
Forever Brands Inc. — partner Nevada corporation entering manufacturing and distribution agreement 2022-07-25 View
ZA Group, Inc. ZLAB partner Parent company of Forever Brands Inc. 2022-07-25 View
Imbibe Wellness Solutions, LLC — partner New York LLC entering manufacturing and distribution agreement 2022-07-25 View
Can B Corp. NASC partner Parent company of Imbibe Wellness Solutions, LLC 2022-07-25 View
Brooke Burke — partner Endorser entering Endorsement Agreement 2022-07-25 View
BB Body, Inc. — partner Company of Brooke Burke entering Endorsement Agreement 2022-07-25 View
Pure Health Products, LLC — supplier Manufacturer producing products under private label agreement 2022-07-25 View
PrimeX LLC — partner Exclusive distributor agreement for CBD and non-CBD products in Brazil and potential international markets. 2022-03-04 View
American Development Partners AIG partner Agreement for development of Health & Wellness products and CBD Lounges 2022-03-04 View
CO Botanicals LLC — customer Buyer in equipment acquisition agreement 2021-08-17 View
TWS Pharma, LLC — supplier Seller of equipment 2021-08-17 View
L7 TWS Pharma, LLC — supplier Seller of equipment 2021-08-17 View
Master Smith Enterprises, LLC — investor Recipient of shares for release of claims 2021-08-17 View
Smith Systems, LLC — investor Recipient of shares for release of claims 2021-08-17 View
Botanix Equities, LLC — partner Counterparty to joint venture processing agreement 2021-08-17 View
Red Road Business Park, LLC — partner Counterparty to lease agreement 2021-08-17 View
Music City Botanicals LLC — supplier Counterparty to asset purchase agreement 2021-08-17 View
Recent 8-K Filings (20)
Filing Date Description Type SEC
2024-10-28 Entry into Material Definitive Agreement; Notice of Delisting or Transfer; Material Modification to Agreement View
2024-06-18 Costs Associated with Exit or Disposal Activities View
2024-05-31 Changes in Registrant's Certifying Accountant View
2024-03-21 Creation of Direct Financial Obligation View
2024-03-20 Completion of Acquisition or Disposition of Assets Acquisition View
2024-03-06 Other Events View
2024-03-01 Other Events View
2024-01-16 Other Events View
2023-12-26 Other Events View
2023-12-05 Triggering Events That Accelerate Obligation View
2023-11-03 Entry into Material Definitive Agreement; Creation of Direct Financial Obligation; Unregistered Sale Agreement View
2023-10-10 Other Events; Financial Statements and Exhibits View
2022-07-25 Entry into Material Definitive Agreement; Financial Statements and Exhibits Agreement View
2022-07-13 Regulation FD Disclosure; Financial Statements and Exhibits View
2022-06-15 Entry into Material Definitive Agreement; Creation of Direct Financial Obligation; Unregistered Sale Agreement View
2022-04-29 Entry into Material Definitive Agreement; Creation of Direct Financial Obligation; Unregistered Sale Agreement View
2022-03-31 Entry into Material Definitive Agreement; Creation of Direct Financial Obligation; Unregistered Sale Agreement View
2022-03-04 Entry into Material Definitive Agreement Agreement View
2022-03-04 Entry into Material Definitive Agreement Agreement View
2021-09-30 Entry into Material Definitive Agreement; Financial Statements and Exhibits Agreement View
Data extracted from SEC EDGAR 8-K filings using NLP. Relationships are as disclosed in filing text. Covers 2021–2026. View on SEC EDGAR

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms